Table 2.
Diet Group | Liver (nmol/g) | Heart (nmol/g) | VAT (nmol/g) | SAT (mol/g) | Plasma (nmol/mL) | Hypothalamus (nmol/g) |
---|---|---|---|---|---|---|
ALA | ||||||
A1 | 898.7 ± 128.3 ab | 102.5 ± 11.8 a | 23926.7 ± 1248.4 ab | 24589.5 ± 1560.4 b | 97.7 ± 13.5 a | ND |
B1 | 1190.2 ± 100.1 b | 208.6 ± 18.9 b | 27737.5 ± 978.7 a | 31367.0 ± 1096.6 a | 112.1 ± 17.2 a | ND |
C1 | 969.6 ± 61.6 ab | 126.2 ± 10.1 a | 22779.2 ± 1710.2 b | 26599.3 ± 1326.9 b | 103.1 ± 7.1 a | ND |
D1 | 596.8 ± 163.3 a | 103.7 ± 15.9 a | 20194.1 ± 1017.2 b | 25711.5 ± 1746.5 ab | 80.8 ± 5.2 a | ND |
EPA | ||||||
A1 | 541.0 ± 92.3 a | 59.4 ± 3.3 a | 407.8 ± 35.6 ab | 506.8 ± 22.6 ab | 64.5 ± 2.9 a | ND |
B1 | 555.9 ± 70.6 a | 61.9 ± 2.9 a | 495.9 ± 38.3 a | 605.9 ± 42.1 a | 65.5 ± 7.2 a | ND |
C1 | 377.1 ± 34.0 ab | 42.7 ± 1.0 b | 284.3 ± 17.9 bc | 386.6 ± 20.6 bc | 55.1 ± 3.1 ab | ND |
D1 | 185.1 ± 59.7 b | 22.2 ± 1.1 c | 169.0 ± 21.8 c | 262.1 ± 28.5 c | 32.3 ± 2.0 b | ND |
DHA | ||||||
A1 | 8242.1 ± 407.5 a | 4318.2 ± 161.8 a | 2604.9 ± 372.5 a | 2403.9 ± 111.3 a | 480.6 ± 16.9 a | 11791.5 ± 881.7 ab |
B1 | 8101.5 ± 514.4 a | 3709.7 ± 115.7 b | 2124.2 ± 187.6 a | 2014.8 ± 134.8 ab | 428.3 ± 48.9 a | 11687.5 ± 349.5 ab |
C1 | 7752.8 ± 394.0 a | 3506.4 ± 95.7 bc | 2307.0 ± 189.3 a | 1986.7 ± 106.9 ab | 439.4 ± 26.1 a | 11331.8 ± 369.2 b |
D1 | 6720.0 ± 671.9 a | 3068.7 ± 201.6 c | 1500.0 ± 264.6 a | 1664.0 ± 23.0 b | 410.4 ± 45.2 a | 13612.8 ± 519.5 a |
n-3 HUFA score | ||||||
A1 | 32.0 ± 0.8 a | 34.6 ± 0.3 a | 22.8 ± 2.4 ab | 23.7 ± 1.0 a | 22.8 ± 0.91 a | 49.8 ± 0.7 a |
B1 | 30.3 ± 0.6 a | 31.9 ± 1.1 a | 23.5 ± 0.8 a | 22.2 ± 0.9 a | 21.2 ± 0.72 ab | 48.9 ± 0.1 ab |
C1 | 28.1 ± 0.2 b | 32.0 ± 1.1 a | 19.3 ± 1.0 b | 18.9 ± 0.7 b | 20.2 ± 0.33 b | 48.3 ± 0.2 b |
D1 | 24.4 ± 0.23 c | 25.1 ± 0.7 b | 14.2 ± 1.1 c | 12.8 ± 0.7 c | 16.2 ± 0.02 c | 47.6 ± 0.2 b |
AA | ||||||
A1 | 19396.2 ± 994.3 a | 9694.9 ± 74.9 a | 8253.3 ± 277.1 a | 8558.3 ± 319.4 b | 2058.7 ± 57.1 a | 8670.8 ± 648.7 b |
B1 | 20722.6 ± 1212.4 a | 9762.2 ± 117.0 a | 8138.1 ± 581.0 a | 8820.2 ± 457.9 b | 2089.9 ± 152.1 a | 9066.6 ± 252.8 b |
C1 | 21505.6 ± 1048.2 a | 9638.7 ± 102.4 a | 9364.8 ± 645.9 a | 10015.1 ± 418.8 b | 2237.5 ± 90.7 a | 9036.5 ± 244.4 b |
D1 | 22810.6 ± 2082.8 a | 9885.1 ± 236.5 a | 10188.2 ± 889.6 a | 12291.9 ± 566.0 a | 2575.2 ± 213.2 a | 11128.7 ± 436.4 a |
CLA | ||||||
A1 | 622.6 ± 66.7 a | 84.1 ± 10.4 a | 19892.6 ± 473.5 a | 17208.7 ± 931.2 a | 58.9 ± 7.3 a | 13.4 ± 0.5 a |
B1 | 416.2 ± 27.9 b | 75.8 ± 8.7 a | 12108.4 ± 396.1 b | 11697.7 ± 424.9 b | 35.6 ± 5.3 b | 17.7 ± 1.3 a |
C1 | 280.7 ± 17.4 c | 43.2 ± 2.9 b | 8218.0 ± 577.4 c | 7911.8 ± 251.0 c | 29.1 ± 1.8 bc | 11.7 ± 1.5 a |
D1 | 58.2 ± 11.1 d | 12.7 ± 2.8 c | 1585.7 ± 171.0 d | 1669.5 ± 181.7 d | 10.9 ± 1.8 c | 11.2 ± 4.8 a |
VA | ||||||
A1 | 529.7 ± 109.7 b | 274.1 ± 5.7 b | 14613.7 ± 200.3 b | 12199.2 ± 968.5 b | 76.6 ± 5.79 a | 656.8 ± 152.5 a |
B1 | 1248.4 ± 249.9 a | 389.7 ± 14.1 a | 35216.2 ± 384.0 a | 30441.6 ± 1602.2 a | 122.5 ± 17.93 a | 693.5 ± 54.7 a |
C1 | 732.1 ± 151.1 bc | 219.6 ± 11.1 c | 19793.3 ± 1407.8 bc | 17789.3 ± 1032.3 bc | 96.3 ± 6.52 ab | 707.0 ± 47.3 a |
D1 | 214.7 ± 82.3 bd | 124.8 ± 5.6 d | 2962.6 ± 342.8 d | 2844.9 ± 212.1 d | 47.5 ± 7.87 b | 744.3 ± 14.3 a |
Values are means ± SEMs, n = 6/group. Within tissue, labelled means in a variable without a common superscript letter differ, as determined by Tukey’s post hoc test after a significant one-way ANOVA, p < 0.05; the maximum value is labeled as ‘a’, the smaller value with difference is marked as ‘b’, the smaller value than ‘b’ with difference is marked as ‘c’, and the smallest value with difference is marked as ‘d’. ND not detected. Subcutaneous (SAT), visceral adipose tissue (VAT); arachidonic acid (AA), n-3 highly-unsaturated fatty acids (n-3 HUFA score). 1 Fats in the diets were: (A) enriched in CLA; (B) enriched in ALA and low in CLA; (C) low in ALA and CLA; (D) high in LA and trace level of CLA.